Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo‐controlled clinical trial with inhaled loxapine

Kwentus J, Riesenberg RA, Marandi M, Manning RA, Allen MH, Fishman RS, Spyker DA, Kehne JH, Cassella JV. Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo‐controlled clinical trial with inhaled loxapine. Bipolar Disord 2012: 14: 31–40. © 2012 The Authors. Journal compilation © 2012 John Wiley & Sons A/S.

[1]  R. N. Brogden,et al.  Loxapine: A Review of its Pharmacological Properties and Therapeutic Efficacy as an Antipsychotic Agent , 1978, Drugs.

[2]  John Battaglia,et al.  Pharmacological Management of Acute Agitation , 2012, Drugs.

[3]  D. Spyker,et al.  Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial. , 2011, The Journal of clinical psychiatry.

[4]  J. Kehne,et al.  Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine , 2011, British Journal of Psychiatry.

[5]  D. Spyker,et al.  Pharmacokinetics of Loxapine Following Inhalation of a Thermally Generated Aerosol in Healthy Volunteers , 2010, Journal of clinical pharmacology.

[6]  F. Pochard,et al.  Enquête sur la prise en charge des patients en état d'agitation dans les services d'accueil et d'urgences en France , 2008 .

[7]  D. Zimbroff.  Pharmacological Control of Acute Agitation , 2008 .

[8]  M. Allen,et al.  Managing the Acutely Agitated and Psychotic Patient , 2007, CNS Spectrums.

[9]  L. Citrome.  Interventions for the treatment of acute agitation. , 2007, CNS spectrums.

[10]  D. Sack,et al.  Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: a randomized, double-blind, placebo-controlled trial. , 2007, The Journal of clinical psychiatry.

[11]  G. Currier,et al.  Standard therapies for acute agitation. , 2004, The Journal of emergency medicine.

[12]  J. Rabinowitz,et al.  Fast Onset Medications through Thermally Generated Aerosols , 2004, Journal of Pharmacology and Experimental Therapeutics.

[13]  G. Currier,et al.  Use of restraints and pharmacotherapy in academic psychiatric emergency services. , 2004, General hospital psychiatry.

[14]  G. Sachs,et al.  Pharmacological management of agitation in emergency settings , 2003, Emergency medicine journal : EMJ.

[15]  S. Lindborg,et al.  Calming versus sedative effects of intramuscular olanzapine in agitated patients. , 2003, The American journal of emergency medicine.

[16]  M. Allen,et al.  Treatment of agitation in bipolar disorder across the life cycle. , 2003, The Journal of clinical psychiatry.

[17]  R. Palmer,et al.  A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. , 2002, Archives of general psychiatry.

[18]  G. Currier,et al.  Pharmacological Treatment of Psychotic Agitation , 2002, CNS drugs.

[19]  L. San,et al.  Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. , 2001, The American journal of psychiatry.

[20]  D. Osser,et al.  Short-term inpatient pharmacotherapy of schizophrenia. , 2001, Harvard review of psychiatry.

[21]  G. Currier,et al.  The Expert Consensus Guideline Series. Treatment of behavioral emergencies. , 2001, Postgraduate medicine.

[22]  D. Conn,et al.  Diagnosing and managing delirium in the elderly. , 2001, Canadian family physician Medecin de famille canadien.

[23]  P. Chue,et al.  Loxapine for schizophrenia. , 2007, The Cochrane database of systematic reviews.

[24]  W. Glazer.  Does loxapine have "atypical" properties? Clinical evidence. , 1999, The Journal of clinical psychiatry.

[25]  P. Buckley,et al.  The role of typical and atypical antipsychotic medications in the management of agitation and aggression. , 1999, The Journal of clinical psychiatry.

[26]  S. Sevy,et al.  Pyramidical model of schizophrenia. , 1990, Schizophrenia bulletin.

[27]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.

[28]  Weiss Kj,et al.  Rapid tranquilization: a comparison of thiothixene with loxapine , 1986 .

[29]  K. Fruensgaard,et al.  Loxapine versus haloperidol parenterally in acute psychosis with agitation , 1977, Acta psychiatrica Scandinavica.

[30]  M. Versiani,et al.  A double-blind comparison between loxapine and haloperidol by parenteral route in acute schizophrenia. , 1977, Current therapeutic research, clinical and experimental.